Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cosmetic Industry Panel's 2010 Priorities Include Triclosan, Talc

This article was originally published in The Tan Sheet

Executive Summary

A cosmetic industry group's research panel set 17 priorities in the 300 ingredients it plans to evaluate in 2010 - including triclosan, used in antibacterial products and toothpastes and the subject of enduring controversy
Advertisement

Related Content

Sunscreen Ingredients Retinyl Palmitate, Oxybenzone Get Second Look
Sunscreen Ingredients Retinyl Palmitate, Oxybenzone Get Second Look
Sunscreen Ingredients Retinyl Palmitate, Oxybenzone Get Second Look
Rep. Calls For Triclosan Ban, Approval Redo, Following FDA, EPA Response
Rep. Calls For Triclosan Ban, Approval Redo, Following FDA, EPA Response
Rep. Calls For Triclosan Ban, Approval Redo, Following FDA, EPA Response
FDA Surveys Cosmetic Products For Asbestos-Contaminated Talc
Environmental Group Opposes FDA Adding Triclosan To OTC Monographs
Environmental Group Opposes FDA Adding Triclosan To OTC Monographs
Triclosan Concern In Congress Spurs Call For Final Antimicrobial Monograph

Topics

Advertisement
UsernamePublicRestriction

Register

PS103966

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel